CHILDREN'S HOSPITAL LOS ANGELES
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1901-04-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.chla.org
N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma
- First Posted Date
- 2005-11-15
- Last Posted Date
- 2023-04-10
- Lead Sponsor
- Children's Hospital Los Angeles
- Target Recruit Count
- 50
- Registration Number
- NCT00253435
- Locations
- 🇺🇸
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus, Atlanta, Georgia, United States
🇺🇸Childrens Hospital Los Angeles, Los Angeles, California, United States
🇺🇸University of Chicago Comer Children's Hospital, Chicago, Illinois, United States
Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
- Conditions
- Interventions
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2015-04-01
- Lead Sponsor
- Children's Hospital Los Angeles
- Target Recruit Count
- 20
- Registration Number
- NCT00140413
- Locations
- 🇺🇸
Childrens Hospital Los Angeles, Los Angeles, California, United States
N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
- Conditions
- First Posted Date
- 2004-10-08
- Last Posted Date
- 2010-10-15
- Lead Sponsor
- Children's Hospital Los Angeles
- Target Recruit Count
- 30
- Registration Number
- NCT00093353
- Locations
- 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸Indiana University Cancer Center, Indianapolis, Indiana, United States
Chemotherapy in Treating Children With Neuroblastoma
- Conditions
- Locations
- 🇺🇸
UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States
🇺🇸Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Children's Hospital Los Angeles, Los Angeles, California, United States
N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation
- Conditions
- First Posted Date
- 2004-05-17
- Last Posted Date
- 2010-10-15
- Lead Sponsor
- Children's Hospital Los Angeles
- Target Recruit Count
- 18
- Registration Number
- NCT00083135
- Locations
- 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸UCSF Comprehensive Cancer Center, San Francisco, California, United States
🇺🇸Children's Hospital Boston, Boston, Massachusetts, United States
Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- Children's Hospital Los Angeles
- Registration Number
- NCT00025324
- Locations
- 🇺🇸
Children's Hospital of the King's Daughters, Norfolk, Virginia, United States
🇨🇦Tom Baker Cancer Centre - Calgary, Calgary, Alberta, Canada
🇺🇸Children's Hospital Los Angeles, Los Angeles, California, United States
Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-07-18
- Lead Sponsor
- Children's Hospital Los Angeles
- Registration Number
- NCT00006258
- Locations
- 🇺🇸
Geisinger Medical Center, Danville, Pennsylvania, United States
🇺🇸Children's Hospital Los Angeles, Los Angeles, California, United States
🇨🇦Tom Baker Cancer Centre - Calgary, Calgary, Alberta, Canada